Winslow Evans & Crocker’s Acceleron Pharma Inc. XLRN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-1,616
| Closed | -$80K | – | 1151 |
|
2018
Q2 | $80K | Hold |
1,616
| – | – | 0.03% | 411 |
|
2018
Q1 | $63.1K | Sell |
1,616
-84
| -5% | -$3.28K | 0.02% | 440 |
|
2017
Q4 | $72.1K | Hold |
1,700
| – | – | 0.02% | 423 |
|
2017
Q3 | $63.4K | Hold |
1,700
| – | – | 0.02% | 434 |
|
2017
Q2 | $51.7K | Buy |
1,700
+440
| +35% | +$13.4K | 0.01% | 550 |
|
2017
Q1 | $33.4K | Hold |
1,260
| – | – | 0.01% | 624 |
|
2016
Q4 | $32.2K | Hold |
1,260
| – | – | 0.01% | 635 |
|
2016
Q3 | $45.6K | Hold |
1,260
| – | – | 0.01% | 559 |
|
2016
Q2 | $42.8K | Sell |
1,260
-140
| -10% | -$4.76K | 0.01% | 548 |
|
2016
Q1 | $36.9K | Buy |
1,400
+400
| +40% | +$10.6K | 0.01% | 566 |
|
2015
Q4 | $48.8K | Hold |
1,000
| – | – | 0.01% | 537 |
|
2015
Q3 | $24.9K | Hold |
1,000
| – | – | 0.01% | 666 |
|
2015
Q2 | $31.6K | Buy |
+1,000
| New | +$31.6K | 0.01% | 656 |
|